ProfileGDS5822 / ILMN_1238246
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 87% 82% 83% 86% 82% 88% 83% 84% 85% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1316.687
GSM1276600PDAC Late Ablation Control 2194.682
GSM1276601PDAC Late Ablation Control 3271.483
GSM1276602PDAC Late Ablation 1295.186
GSM1276603PDAC Late Ablation 2193.882
GSM1276604PDAC Late Ablation 3427.288
GSM1303940PDAC Late Ablation_anti-CTLA4 1186.883
GSM1303941PDAC Late Ablation_anti-CTLA4 2286.284
GSM1303942PDAC Late Ablation_anti-CTLA4 3304.385